BNP Paribas Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,264,796
| Closed | -$13.1M | – | 833 |
|
|
2020
Q2 | $13.1M | Sell |
1,264,796
-634,814
| -33% | -$6.55M | 0.09% | 254 |
|
|
2020
Q1 | $19.2M | Sell |
1,899,610
-4,619
| -0.2% | -$46.6K | 0.16% | 172 |
|
|
2019
Q4 | $25.3M | Buy |
1,904,229
+511,860
| +37% | +$6.81M | 0.17% | 166 |
|
|
2019
Q3 | $12M | Buy |
1,392,369
+553,859
| +66% | +$4.75M | 0.09% | 267 |
|
|
2019
Q2 | $9.17M | Buy |
838,510
+53,183
| +7% | +$582K | 0.07% | 311 |
|
|
2019
Q1 | $8.9M | Buy |
785,327
+190,112
| +32% | +$2.15M | 0.07% | 324 |
|
|
2018
Q4 | $4.94M | Sell |
595,215
-816,837
| -58% | -$6.78M | 0.05% | 447 |
|
|
2018
Q3 | $21.8M | Sell |
1,412,052
-204,316
| -13% | -$3.16M | 0.17% | 171 |
|
|
2018
Q2 | $25.9M | Sell |
1,616,368
-419,371
| -21% | -$6.72M | 0.22% | 121 |
|
|
2018
Q1 | $26.3M | Sell |
2,035,739
-146,128
| -7% | -$1.89M | 0.22% | 126 |
|
|
2017
Q4 | $27.4M | Buy |
2,181,867
+16,550
| +0.8% | +$208K | 0.23% | 103 |
|
|
2017
Q3 | $28.6M | Buy |
2,165,317
+839,496
| +63% | +$11.1M | 0.24% | 93 |
|
|
2017
Q2 | $21M | Sell |
1,325,821
-86,478
| -6% | -$1.37M | 0.19% | 124 |
|
|
2017
Q1 | $20.2M | Buy |
1,412,299
+133,064
| +10% | +$1.9M | 0.19% | 125 |
|
|
2016
Q4 | $16.4M | Buy |
1,279,235
+465,132
| +57% | +$5.96M | 0.16% | 161 |
|
|
2016
Q3 | $10.8M | Buy |
+814,103
| New | +$10.8M | 0.09% | 299 |
|